Company
Ajax Therapeutics
| Industry | biopharmaceutical company developing JAK inhibitors for patients with myeloproliferative neoplasms (MPNs) |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Ajax Therapeutics | series c | 2024-05-13 |
Company
| Industry | biopharmaceutical company developing JAK inhibitors for patients with myeloproliferative neoplasms (MPNs) |
|---|
| Company | Round | Date |
|---|---|---|
| Ajax Therapeutics | series c | 2024-05-13 |